Table 1. Baseline patient characteristics.
| Total | Survived Until day 28 | Deceased by day 28 | P-Value | |
|---|---|---|---|---|
| Age [years], median (IQR) | 61.5 (50–73.25) | 59 (46.25–70) | 74.5 (65.25–84.75) | 1.20E-10 |
| Male gender, n (%) | 194 (59.9%) | 157 (59%) | 37 (63.8%) | 0.61 |
| BMI n (%) | 0.77 | |||
| < 18.5 | 2 (0.6%) | 2 (0.8%) | 0 (0%) | |
| 18.5-< 25 | 58 (17.9%) | 46 (17.3%) | 12 (20.7%) | |
| 25-< 30 | 120 (37%) | 100 (37.6%) | 20 (34.5%) | |
| >30 | 143 (44.1%) | 117 (44%) | 26 (44.8%) | |
| Ethnicity n (%) | 0.00012 | |||
| Hispanic | 129 (39.8%) | 119 (44.7%) | 10 (17.2%) | |
| Non-Hispanic | 153 (47.2%) | 112 (42.1%) | 41 (70.7%) | |
| Unknown | 42 (13%) | 35 (13.2%) | 7 (12.1%) | |
| Diabetes n (%) | 128 (39.5%) | 99 (37.2%) | 29 (50%) | 0.18 |
| Heart Failure n (%) | 45 (13.9%) | 26 (9.8%) | 19 (32.8%) | 6.16E-07 |
| COPD or emphysema n (%) | 40 (12.3%) | 23 (8.6%) | 17 (29.3%) | 0.00012 |
| Lab values | ||||
| PCT median (IQR) | 0.17 (0.10–0.34) | 0.15 (0.09–0.25) | 0.32 (0.15–1.17) | 8.10E-06 |
Baseline characteristics of the full study population and comparison between survival and deceased patient cohorts.